CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Anna Stasiłowicz-Krzemień - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Anna Stasiłowicz-Krzemień

OPENALEX: A5070187736↗ORCID: 0000-0001-5211-661X↗

Affiliations

Organizations

Poznan University of Medical Sciencesauthorship · PL

Public evidence

6 connected articles

Antimicrobial, Probiotic, and Immunomodulatory Potential of <i>Cannabis sativa</i> Extract and Delivery Systems.2024 · Europe PMC The Use of Compounds Derived from <i>Cannabis sativa</i> in the Treatment of Epilepsy, Painful Conditions, and Neuropsychiatric and Neurodegenerative Disorders.2024 · Europe PMC 3D Printed Bigel: A Novel Delivery System for Cannabidiol-Rich Hemp Extract.2024 · Europe PMC Determining Antioxidant Activity of Cannabis Leaves Extracts from Different Varieties-Unveiling Nature's Treasure Trove.2023 · Europe PMC Co-Dispersion Delivery Systems with Solubilizing Carriers Improving the Solubility and Permeability of Cannabinoids (Cannabidiol, Cannabidiolic Acid, and Cannabichromene) from <i>Cannabis sativa</i> (Henola Variety) Inflorescences.2023 · Europe PMC <i>Cannabis sativa</i> L. as a Natural Drug Meeting the Criteria of a Multitarget Approach to Treatment.2021 · Europe PMC

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.